Journal of Medicinal Chemistry p. 2418 - 2426 (1995)
Update date:2022-08-03
Topics:
Dodic, Nerina
Dumaitre, Bernard
Daugan, Alain
Pianetti, Pascal
A number of tricyclic carboxamides have been synthesized and tested to evaluate their ability to reverse multidrug resistance in the CHRC/5 cell line.Among them the acridone derivatives were the most potent.A key feature is the presence of a dimethoxybenzyl or phenethylamine cationic site, separated from the tricyclic lipophilic part by a carbamoylphenyl chain.Optimization led to compounds 2 orders of magnitude more active than the prototype inhibitors verapamil and amiodarone.On the basis of in vitro and in vivo activities, 9,10-dihydro-5-methoxy-9-oxo-N-<4-<2-(1,2,3,4-tetrahydro-6,7-dimethoxyisoquinol- 2-yl)ethyl>phenyl>-4-acridinecarboxamide (84) has been selected for further development.
View Morelianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Contact:+49-4101-3053-0
Address:Waldhofstrasse 14 ,25474 Ellerbek Germany
RongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Contact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
Chengdu Chengnuo New-Tech Co., Ltd
Contact:0086-028-85749078
Address:4 Jiuyang road,Jiulong industrial port,Chengdu, China
Doi:10.1002/chem.201400301
(2014)Doi:10.1021/jo001589n
(2001)Doi:10.1021/jacs.6b00764
(2016)Doi:10.1016/S0957-4166(99)00519-4
(2000)Doi:10.1246/bcsj.43.2130
(1970)Doi:10.1016/0008-6215(94)00306-Z
(1995)